50% off Premium Yearly

TSE:ATS
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. It is sensitive to broad economic growth and is likely why the shares are dragging down. Trading at 16x forward earnings and good growth is expected. Risks are most likely already priced in. Cost pressures and slowdowns are possible, but many companies, including ATA will manage through them. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The stock is up more than 100% in the past year. It has slightly declined but it is more on sell on news right now. EPS estimates beat last quarter. Backlog is nearly $1.5B and sales are climbing 48%. A solid quarter. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Could deliver good growth although it is more in the cyclical business. Business is solid and the stock has hit more investor’s radar. 3 year + timeframe. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Earnings report was overall good. Revenues beat expectations by $20M. Backlog is up 23% to $1.1B and EPS is $0.34. EBITDA margins have increased. Their acquisition of BioDot is going well. Shares are up 4% after the report. Unlock Premium - Try 5i Free